Skinvisible Web Sign Up for Updates         T 702.433.7154   |   F 702.433.7192
Skinvisible - Polymer Delivery System

The Ultimate Polymer Delivery System.
November 12, 2003

UNLV Athletic Department Introduces Skinvisible(R) to Help Fight Infection

LAS VEGAS, Nov 12, 2003 /PRNewswire-FirstCall via COMTEX/ --

Skinvisible, Inc. (OTC Bulletin Board: SKVI) (Website: www.skinvisible.com) has announced that its wholly owned subsidiary Skinvisible Pharmaceuticals, Inc. has reached an agreement with The University of Nevada, Las Vegas (UNLV), to supply its athletic department with its patented antimicrobial skin sanitizer lotion to help prevent the spread of methicillin-resistant staphylococcus aureus, or MRSA, a skin infection bacteria that is increasingly affecting athletes.

UNLV is the first college athletic facility to use the Skinvisible(R) product, making it available to approximately 500 student athletes who train and compete at the university on a daily basis. 'We are very pleased to have been introduced to this new product,'says UNLV Athletic Trainer Kyle Wilson. 'We feel it is important to take a pro-active approach in the prevention to the spread of infectious germs, including MRSA, amongst our student athletes. We're confident that this product can help us achieve that goal.'

'Independent studies conclude that the Skinvisible(R) skin sanitizer, which is formulated with Triclosan as the active ingredient, demonstrates a superior bacteriostatic and/or bactericidal effect against a broad spectrum of test pathogens, including MRSA,'reports Dr. James Roszell, head chemist at Skinvisible. 'When topically applied, independent studies verify that this lotion delivers a continuous, long-term bacterial kill of up to 99.9% for up to four hours per application, which is undiminished by hand washing or perspiration.'

In a recent USA Today article, reporter Gary Mihoces notes several cases of MRSA amongst high school, college and professional sports teams. In September 2003, several members of the NFL's Miami Dolphins were infected by MRSA. As well, the Center for Disease Control and Prevention (CDC) reports that a fencing club in Colorado, a college football team in Pennsylvania and a number of high school wrestlers in Indiana, have recently been hit by MRSA. The report concludes that the spread of MRSA is a growing concern among the general population.

'Skinvisible is proud to have UNLV be the first to offer our product to their student athletes and we look forward to introducing our product to other schools and athletic organizations across the country,'says Terry Howlett, CEO of Skinvisible, Inc.

In a Press Release dated October 30 the company announced that Health First Distributors North America, Inc. (website www.hfdna.com) had purchased the marketing rights for the Skinvisible Hand Sanitizer Lotion product. Product is available in the US by calling toll-free 877.925. 6000, in Canada toll-free 877.684.6999

Headquartered in Las Vegas, Nevada, Skinvisible, Inc. is focused on the development of innovative topical polymer-based delivery systems and related technologies incorporating its patent-pending formula/process for combining hydrophilic and hydrophobic polymers into stable water emulsions. Skinvisible's primary marketing and sales objectives are to license its technologies and/or sell its delivery systems to provide enhanced product performance for established brand manufacturers and providers of prescription, over-the-counter, cosmetic, and skincare products. In addition Skinvisible formulates and manufactures products for private label customers.

This press release contains 'forward looking'statements within the meaning of Section 21A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934 as amended, and are subject to the safe harbors created thereby. Such statements involve certain risks and uncertainties associated with an emerging company. Actual results could differ materially from those projected in the forward looking statements as a result of risk factors discussed in Skinvisible, Inc. reports that will be on file with the US Securities and Exchange Commission (including but not limited to the report on Form 10-QSB for the quarter ending June 30, 2003).

For further information, please contact T. Howlett of Skinvisible, Inc., +1-702-433-7154, or fax, +1-702-433-7192, terry@skinvisible.com; or Tommi Hanley of Thompson Lloyd Communications, +1-250-860-9959, tommi.tlc@shaw.ca, for Skinvisible, Inc.
  Press Release Index
New Press Release Alerts:


Click here to join our mailing list.
Home    |     About us    |    Technology    |    Products    |    Investors    |    Contact Us    |    Disclaimer & Privacy    |     Sign Up for Updates
© 2008 Skinvisible Pharmaceuticals, Inc.     Note: This website is not intended for Canadian residents.